Cue Biopharma (CUE) Non-cash Items (2018 - 2025)

Cue Biopharma has disclosed Non-cash Items across 8 years of filings, most recently posting $7.3 million for Q4 2025.

• Non-cash Items for Q4 2025 came in at $7.3 million, up 42.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.3 million (up 42.63% YoY), and the FY2025 annual result was $7.3 million, up 42.63% from the prior year.
• Non-cash Items came in at $7.3 million for Q4 2025 at Cue Biopharma, up from $7.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $7.3 million in Q4 2025 to a low of $3.1 million in Q1 2021.
• The 5-year median for Non-cash Items is $4.4 million (2022), against an average of $4.8 million.
• Across the five-year window, Non-cash Items grew 0.18% in 2023 and jumped 42.63% in 2025, its largest moves.
• Cue Biopharma's Non-cash Items stood at $3.6 million in 2021, then rose by 23.57% to $4.4 million in 2022, then rose by 4.53% to $4.6 million in 2023, then grew by 11.97% to $5.1 million in 2024, then surged by 42.63% to $7.3 million in 2025.
• The last three Non-cash Items figures came in at $7.3 million (Q4 2025), $7.2 million (Q3 2025), and $6.3 million (Q2 2025), per Business Quant data.